| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Scientific Officer | President &CSO
1 company
Shacham Sharon is a Chief Scientific Officer at Karyopharm Therapeutics Inc.. Recent SEC Form 4 filings include 0 buys and 21 sells.
Estimated insider holdings value: $8.6M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jun 22, 2020 | KPTI Karyopharm Therapeutics Inc. | President &CSO | Sale+OE | 7,500 | $20.00 | $150,000.00 | -1.0% | |
| Jun 15, 2020 | KPTI Karyopharm Therapeutics Inc. | President &CSO | Sale+OE | 7,500 | $16.37 | $122,779.31 | -0.5% | |
| Jun 10, 2020 | KPTI Karyopharm Therapeutics Inc. | President &CSO | Sale+OE | 15,000 | $18.31 | $274,689.75 | -1.1% | |
| May 18, 2020 | KPTI Karyopharm Therapeutics Inc. | President &CSO | Sale+OE | 15,000 | $19.32 | $289,840.50 | -1.0% | |
| May 7, 2020 | KPTI Karyopharm Therapeutics Inc. | President &CSO | Sale+OE | 15,000 | $19.63 | $294,414.00 | -1.1% | |
| Apr 9, 2020 | KPTI Karyopharm Therapeutics Inc. | President &CSO | Sale+OE | 20,000 | $19.63 | $392,519.00 | -1.5% | |
| Mar 10, 2020 | KPTI Karyopharm Therapeutics Inc. | President &CSO | Sale+OE | 20,000 | $22.37 | $447,380.57 | -0.8% | |
| Feb 19, 2020 | KPTI Karyopharm Therapeutics Inc. | President &CSO | Sell | 17,634 | $16.48 | $290,641.82 | -1.3% | |
| Feb 11, 2020 | KPTI Karyopharm Therapeutics Inc. | President &CSO | Sale+OE | 20,000 | $17.18 | $343,621.00 | -1.5% | |
| Jan 9, 2020 | KPTI Karyopharm Therapeutics Inc. | President &CSO | Sale+OE | 20,000 | $18.88 | $377,585.00 | -1.5% |